Published in Immunotherapy Weekly, February 4th, 2004
According to recent research published in the European Journal of Pharmacology, "15-deoxy-Delta12,14-prostaglandin J2 (15d-prostaglandin J2 ) has received attention for its anti-inflammatory properties. The present study investigated the efficacy of 15d-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice. ICR mice were administered with 15d-prostaglandin J2 (10 microgram/kg, 100 microgram/kg, or 1 mg/kg) before intratracheal challenge with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.